Perrigo | PRGO - Debt


Perrigo reported $3.64B in Debt for its fiscal quarter ending in December of 2025.





Debt Change Date
AbbVie USD 67.5B 67.5B Dec/2025
Abbott USD 34.05B 20.19B Mar/2026
Bayer EUR 36.45B 2.93B Dec/2025
Bristol-Myers Squibb USD 47.14B 3.9B Dec/2025
Coherus Biosciences USD 294.92M 1.25M Mar/2025
Corcept Therapeutics USD 6.11M 251K Dec/2025
Dr.Reddys Laboratories INR 67.73B 9.19B Dec/2025
Eli Lilly USD 42.5B 3.6M Dec/2025
J&J USD 54.99B 7.05B Mar/2026
Merck USD 49.34B 7.97B Dec/2025
Nestle CHF 54.31B 285M Dec/2022
Pacira USD 367.66M 4.53M Mar/2026
Perrigo USD 3.64B 4.5M Dec/2025
Pfizer USD 63.73B 231M Mar/2026
Phibro Animal Health USD 474.17M 730K Sep/2024
Prestige Brands USD 1.08B 38.27M Dec/2025
Reckitt Benckiser GBP 8.66B 238M Dec/2024
Sanofi EUR 20.33B 1.43B Dec/2025
Supernus Pharmaceuticals USD 40.98M 1.23M Dec/2025
Teva Pharmaceutical Industries USD 17.09B 21M Dec/2025
Xeris Pharmaceuticals USD 258.55M 899K Mar/2026
Zoetis USD 9.24B 1.96B Dec/2025